News

Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.

Platinum Dermatology Partners and West Dermatology merged in June 2022 and now have completed a post-integration rebranding.

Both companies are hoping to make a positive impact in the neoadjuvant setting of cutaneous squamous cell carcinoma.

Discover why exempt assets, tenancy by the entirety, limited liability companies, and trusts can be key tools in finance management.

In this month’s Legal Eagle column, learn the ins and outs of being called as an expert witness in a medical malpractice case.

Learn more about the in-depth topics covered in the July 2023 issue of Dermatology Times®.

The company is set to meet with the FDA in August to discuss the epidermolysis bullosa drug’s anticipated BLA.

Shari Lipner, MD, PhD, FAAD, shared advice for providers and patients in the event of nail injuries.

Study authors also found that location of the birthmark and skin tone affected degree of improvement.

Researchers found that topical application of the carboxy mask led to improvements in skin firmness, sagging, tone, and wrinkles.

Keep up with the latest headlines in dermatology from the past week, including rising incidences of skin cancer, dermatologists' responses to viral social media skin care tips, and more.

Researchers have isolated 2 genes, SOX9 and KLF5, that play a role in the development of hidradenitis suppurativa.

ICYMI, this week we had stories about the psychological effects of cosmetic procedures, upadacitinib phase 3 trial for hidradenitis suppurativa, decreased levels of vitamin D associated with psoriasis severity, and more.

Each month, Dermatology Times® features a roundup of products trending in consumer skin care. Find out what products are popular for the month of July.

This increased risk was particularly heightened among pediatric patients who fell under an anxious pre-occupied subcategory.

Skin responses to lactic acid sting and capsaicin tests varied, according to researchers.

Researchers assessed the effectiveness of oxybutynin in the gel and nanoemulgel forms and found both reduced scores on the Hyperhidrosis Disease Severity Scale.

V940-001 is the first phase 3 study of a planned comprehensive clinical development program initiated after the positive primary analysis of the phase 2b KEYNOTE-942/mRNA-4157-P201 trial.

Celebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.

These findings come from one of the largest related studies to date.

The National Rosacea Society survey revealed only 3% of patients had coverage for laser treatments.

Recent advancements in the understanding of epidermolysis bullosa have resulted in a fine-tuning of the classification of the disease group as well as the development of new possible therapies.

An anonymous, online survey was conducted through HS support groups from June 2022 to July 2022.

Study authors found that injection with a needle resulted in a higher incidence of ecchymosis.

AbbVie announced that patients treated with risankizumab achieved significantly higher results than those given apremilast.

Researchers found that lipid profile levels were higher in patients with acne vulgaris compared to otherwise healthy patients.

This week’s collection of the latest dermatologic studies covers benzoyl peroxide gel with oral doxycycline compared to lymecycline, interactions between the aesthetic device industry and dermatologists, nasal soft tissue pliability, and Merkel cell carcinoma in situ with reticulated infundibulocystic proliferation.

Furthermore, a survey showed that more than half of providers do not discuss clothing modifications, and half report providing patients with wound care supplies that are covered by insurance.

Quality of life is impacted far beyond the physical challenges for those with oculocutaneous albinism.

Researchers found that treatment for atopic dermatitis could contribute to a higher mutation rate.